M. V. Cannizzaro

Comparison of a novel treatment protocol with oral fluconazole vs probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 in the treatment of recurrent vulvovaginal candidiasis

R. Sorge, M. Ciotti, C. Pensa, 2022, Italian Journal of Gynaecology and Obstetrics.

Efficacy of certolizumab pegol in naïve versus multi-treated patients affected by psoriatic arthritis

E. Candi, A. Dattola, S. Mazzilli, 2021, Italian Journal of Dermatology and Venereology.

Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa

K. Peris, S. Giustini, S. Garcovich, 2022, Journal of Clinical Medicine.

Treatment Adherence to Different Etanercept Regimens, Continuous vs. Intermittent, in Patients Affected by Plaque‐Type Psoriasis

S. Chimenti, P. Gisondi, G. Babino, 2014, Drug development research.

Brodalumab in the Treatment of Plaque Psoriasis Localized in Difficult-to-Treat Areas: A Narrative Review

A. Chiricozzi, G. Coscarella, M. V. Cannizzaro, 2023, Dermatology practical & conceptual.

Increased levels of IL‐17 in tear fluid of moderate‐to‐severe psoriatic patients is reduced by adalimumab therapy

B. Marinari, S. Chimenti, A. Costanzo, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.